NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

MultiSCRIPT-Cycle 1: Personalized Medicine in Multiple Sclerosis - Pragmatic Platform Trial Embedded Within the SMSC

Active Not RecruitingNA

Sponsor: University Hospital, Basel, Switzerland

Conditions: Multiple Sclerosis, Relapsing-Remitting

Interventions: serum Neurofilament Filament Light chain (sNfL) monitoring

Countries: Switzerland

This is a randomized pragmatic clinical trial fully embedded in the Swiss Multiple Sclerosis Cohort to assess whether sNfL biomarker monitoring improves patient-relevant outcomes and care of patients with relapsing-remitting (RR)MS by either increasing the proportion of patients with no evidence of disease activity (EDA) or by improving patients' health-related quality of life.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Diagnosis of RRMS according to the most recent McDonald criteria (2017) for at least one year
* Have already consented to take part in the SMSC
* Age 18 years old or older
* Able and willing to consent

Exclusion Criteria:

* Inclusion or planned inclusion in another clinical trial that determines the drug therapy for MS for the purpose of research as these patients are most likely not following the SMSC usual care.

Locations (8)

Basel, Canton of Basel-City, Switzerland
Aarau, Switzerland
Bern, Switzerland
Geneva, Switzerland
Lausanne, Switzerland
Lugano, Switzerland
Sankt Gallen, Switzerland
Zurich, Switzerland